Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute and subacute weakness.

Marguerite Hill1

  • 1Institute of Clinical Neurosciences, Frenchay Hospital, Bristol. marguerite.hill@bristol.ac.uk

Clinical Medicine (London, England)
|May 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update).

Practical neurology·2025
Same author

Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experience.

Journal of neurology, neurosurgery, and psychiatry·2025
Same author

The Association of British Neurologists' myasthenia gravis guidelines.

Annals of the New York Academy of Sciences·2017
Same author

Interventions for dysphagia in long-term, progressive muscle disease.

The Cochrane database of systematic reviews·2016
Same author

Myasthenia gravis: Association of British Neurologists' management guidelines.

Practical neurology·2015
Same author

WITHDRAWN: Treatment for swallowing difficulties (dysphagia) in chronic muscle disease.

The Cochrane database of systematic reviews·2014
Same journal

Letter to the Editor: 'Life expectancy of UK physicians in the early 21st century: An analysis of 1,000 fellows from the Royal College of Physicians' Munk's Roll'.

Clinical medicine (London, England)·2026
Same journal

Finerenone Exposure and Ischemic Stroke in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Propensity Score-Matched Cohort Study.

Clinical medicine (London, England)·2026
Same journal

Prevalence and predictive factors of chronic kidney disease among individuals with cardiometabolic risk factors: A multicenter cross sectional study, North East Ethiopia.

Clinical medicine (London, England)·2026
Same journal

Authors' response to Dr Lucy Williams' letter to the Editor: 'Life expectancy of UK physicians in the early 21st century: An analysis of 1,000 fellows from the Royal College of Physicians' Munk's Roll'.

Clinical medicine (London, England)·2026
Same journal

Resident doctor workforce wellbeing worldwide: lessons between the United Kingdom and Australia.

Clinical medicine (London, England)·2026
Same journal

Premature ventricular complexes.

Clinical medicine (London, England)·2026
See all related articles

Monitor respiratory failure in neuromuscular disease using vital capacity and respiratory rate. Treatments like plasma exchange and IVIg aid recovery in conditions such as Guillain-Barré syndrome and myasthenic crisis.

Area of Science:

  • Neurology
  • Respiratory Medicine

Background:

  • Respiratory failure is a frequent complication in acute neuromuscular diseases and high cervical cord injuries.
  • Monitoring respiratory function is crucial for managing these conditions.

Purpose of the Study:

  • To outline key monitoring parameters for respiratory failure in neuromuscular disease.
  • To highlight effective treatments for specific neuromuscular disorders.
  • To emphasize diagnostic considerations for acute proximal weakness.

Main Methods:

  • Monitoring forced vital capacity and respiratory rate for respiratory compromise.
  • Utilizing urgent imaging for suspected spinal cord disease.
  • Administering plasma exchange or intravenous immunoglobulin (IVIg) for Guillain-Barré syndrome and myasthenic crisis.

Related Experiment Videos

  • Evaluating drug side effects or metabolic disturbances in cases of acute proximal weakness.

    • Main Results:

    • Forced vital capacity and respiratory rate are essential monitoring tools for respiratory failure.
    • Plasma exchange or IVIg accelerates recovery in Guillain-Barré syndrome.
    • Plasma exchange or IVIg provides short-term improvement in myasthenic crisis.
    • Drug side effects or metabolic disturbances are important considerations for acute proximal weakness.

    Conclusions:

    • Effective monitoring and timely intervention are critical for managing respiratory failure in neuromuscular diseases.
    • Specific treatments like plasma exchange and IVIg can significantly improve outcomes.
    • Differential diagnosis for acute proximal weakness should include iatrogenic and metabolic causes.